Timetable icon Self-scheduling is currently available for select locations!

ReSTOR +3.0 Now Available!

January 18, 2009

I mentioned last month that the FDA approved Alcon’s ReSTOR +3.0 multifocal IOL.  I am pleased the this new IOL is now available for implantation.  In fact, I was able to implant the first one in New Jersey last Wednesday.

The clinical studies of the new ReSTOR +3.0, that was submitted to the FDA, showed several advantages over the ReSTOR +4.0 that has been in use for the past few years:
  • Reading distance for the +3.0 is 16 to 20 inches, compared to 13 inches for the +4.0.
  • There was a 1 1/2 line of improved intermediate vision with the +3.0 (20/25) compared to the +4.0 (20/40).
  • 95% of +3.0 patients were able to see 20/40 or better at distance and intermediate compared to 72% of +4.0 patients.
  • +3.0 patients were able to see a broader range of 20/20 near vision.  There was a larger “sweet spot” for near vision and reading tasks.
  • +3.0 patients were able to experience the benefits of the lens sooner than those with the +4.0.
  • About 78% of ReSTOR patients (both +3.0 and +4.0) never wear glasses, another 21% occasionally wear glasses.
  • 96% of +3.0 patients indicated that they would choose to have the implant again!

TAKE HOME MESSAGE:  Results of the ReSTOR +4.0 have been excellent.  Most of my patients have been able to both read and drive without glasses.  One shortcoming of this lens has been a “dead spot” in the vision.  Intermediate vision has been difficult and many patients needed a pair of OTC readers to work at the computer range.  The introduction of the ReSTOR +3.0 appears to have addressed this issue.  Patients can expect to have improved intermediate vision to go along with excellent near and far vision!

Back to our blog

Services offered at OCLI

Our world-class team of professionals at OCLI can help you with the latest treatment options for you.

Schedule an appointment

Are you a new patient? *